Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-09

FDA Approved: BRIVARACETAM — Original Application (SolarisPharmaCorporation)

View source ↗

Summary

FDA approved an abbreviated new drug application for brivaracetam (generic) by SolarisPharmaCorporation under ANDA214748, enabling a generic version of Brivarac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM)